- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | GlucoModicum's non-invasive CGM nears first filing | ||
| Mi | Shionogi puts up to $600m behind BioVersys antibiotics | ||
| Mi | New passport 'will speed medtech rollout in NHS' | ||
| Mi | AstraZeneca CEO Soriot said to be looking at US listing | ||
| Mi | The US Senate has passed Trump's budget - what comes next? | ||
| Di | Beckley psychedelic hits the target, unlocking atai merger | ||
| Di | Barriers are limiting UK childhood vaccination, say doctors | ||
| Di | New medicine access times to be slashed under NHS plan | ||
| Di | Amgen's Five Prime takeover delivers gastric cancer win | ||
| Di | AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline | ||
| Mo | Moderna shines spotlight on new flu vaccine data | ||
| Mo | INmune Bio slumps on midstage fail for Alzheimer's drug | ||
| Mo | Generic drugmaker Hikma pledges $1bn in US investment | ||
| Mo | FDA loosens restrictions on first-gen CAR-T therapies | ||
| Mo | Neopharmed buys Euro rights to BioCryst's HAE drug Orladeyo | ||
| Fr | Novo Nordisk Foundation gives $75m for R&D 'challenges' | ||
| Fr | Controversial project aims to make artificial human genomes | ||
| Fr | After FDA says no, Bayer bags EU nod for twice-yearly Eylea | ||
| 26.06. | ACIP backs block on flu vaccines with thimerosal additive | ||
| 26.06. | UK probes link between GLP-1 drugs and pancreatitis | ||
| 26.06. | First intranasal anaphylaxis drug launches in Germany | ||
| 26.06. | Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen | ||
| 26.06. | Nektar eyes pivotal trials for eczema drug cast off by Lilly | ||
| 26.06. | Could a vaccine adjuvant be protective against dementia? | ||
| 26.06. | Biogen races into phase 3 with Spinraza follow-up |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .